Cutter & CO Brokerage Inc. Buys New Stake in Vivos Therapeutics, Inc. (NASDAQ:VVOS)

Cutter & CO Brokerage Inc. bought a new stake in Vivos Therapeutics, Inc. (NASDAQ:VVOS) during the fourth quarter, HoldingsChannel reports. The institutional investor bought 38,100 shares of the company’s stock, valued at approximately $163,000.

Vivos Therapeutics Trading Up 3.0 %

Shares of NASDAQ VVOS opened at $3.45 on Thursday. Vivos Therapeutics, Inc. has a 12-month low of $1.91 and a 12-month high of $6.28. The stock has a market cap of $20.32 million, a P/E ratio of -0.61 and a beta of 7.47. The business’s fifty day simple moving average is $4.37 and its 200-day simple moving average is $3.49.

Analysts Set New Price Targets

VVOS has been the topic of a number of recent research reports. Alliance Global Partners cut their price target on shares of Vivos Therapeutics from $8.25 to $6.00 and set a “buy” rating on the stock in a research note on Tuesday, November 19th. Ascendiant Capital Markets reaffirmed a “buy” rating and set a $6.60 target price on shares of Vivos Therapeutics in a research note on Wednesday, November 20th.

About Vivos Therapeutics

Vivos Therapeutics, Inc, a medical technology company, develops and commercializes treatment modalities for patients with dentofacial abnormalities, obstructive sleep apnea (OSA), and snoring in adults. It offers The Vivos Method, a non-invasive, non-surgical, non-pharmaceutical, multi-disciplinary treatment modality for the treatment of dentofacial abnormalities, OSA, and snoring.